Disclosure of interest: Nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P666 - ESOC25-2405 BRIDGING INTRAVENOUS THROMBOLYSIS IS ASSOCIATED WITH FASTER RECANALIZATION IN PATIENTS UNDERGOING THROMBECTOMY FOR ISCHAEMIC STROKE DUE TO LARGE ARTERY ATHEROSCLEROSIS Annahita Sedghi 1 , Daniel Kaiser 1 , Witold Polanski 1 , Martin Arndt 1 , Kristian Barlinn 1 , Volker Puetz 1 , Timo Siepmann 1 1 Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Background and Aims: A recent study suggested that bridging intravenous thrombolysis (IVT) for large vessel occlusion LVO may alter clot architecture and facilitate rapid clot removal during thrombectomy, but this may vary by stroke etiology

It is a question increasingly asked as interest in novel weight-management and hormone-optimising compounds grows, but the answer is far from straightforward
Inject a small dose of BPC-157 subcutaneously (250 to 600 micrograms daily, in my protocols) and your body responds the way it already knows how
We note that these changes can be a result of different factors, including updated data, payment weight changes, and changes in policy
It has been studied in scientific contexts and is actively discussed in longevity, sleep, and peptide medicine communities